In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CI 77220 Drug Master File in Korea (CI 77220 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CI 77220. The MFDS reviews the CI 77220 KDMF as part of the drug registration process and uses the information provided in the CI 77220 KDMF to evaluate the safety and efficacy of the drug.
After submitting a CI 77220 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CI 77220 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CI 77220 suppliers with KDMF on PharmaCompass.